使用阿弗利伯塞普特8毫克治疗先前和预先治疗的糖尿病黄斑胀的十二个月结果:瑞士视网膜研究网络报告
Jan Spindler1, Dmitri Artemiev2, Isabel B Pfister1
1Berner Augenklinik and Swiss Eye Institute, Bern, Switzerland.
Ophthalmology science
|March 5, 2026
概括
内阿弗利塞普特8毫克 (Afl 8) 有效治疗糖尿病黄斑胀 (DME),改善视力和减少视网膜厚度. 这种疗法允许延长治疗间隔,为新的和以前接受过治疗的DME患者提供了一个有前途的选择.
科学领域:
- 眼科医生 眼科 眼科
- 视网膜疾病 视网膜疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病黄斑 (DME) 是糖尿病患者视力丧失的主要原因.
- 目前的抗VEGF疗法需要频繁注射,影响患者负担和治疗费用.
研究的目的:
- 为了评估高剂量静脉内阿弗利塞普特8毫克 (Afl 8) 对DME的实际有效性和安全性.
- 在未经治疗的眼睛和预处理的DME眼睛中评估Afl 8.
主要方法:
- 在12个月内对156个DME眼睛进行了回顾性,多中心的队列研究.
- 收集了视力敏度,视网膜厚度,治疗间隔和不良事件的数据.
- 在未接受过治疗和接受过预治疗的患者组之间比较结果.
主要成果:
- Afl 8 改善了视力敏度,并减少了 DME 眼睛的中部子场厚度.
- 观察到治疗间隔延长,特别是在预处理的眼睛.
- 报告的不良事件率较低,在预治疗组中发现了轻微的非传染性眼内炎症.
结论:
- 高剂量静脉注射aflibercept 8 mg (Afl 8) 是有效和安全的DME管理.
- Afl 8促进了延长剂量间隔,可能减少治疗负担.
- 这种疗法对耐火性DME病例有希望,尽管轻微的眼内炎症需要监测.
更多相关视频
11:03Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy
Published on: January 22, 2018
9.7K
05:14Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
1.7K
相关概念视频
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Diabetic Retinopathy
66
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
66
